Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
cAd3-EBO Z and MVA-BN Filo in Malian adults
NCT02267109Phase 1Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Oct 2014
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cAd3-EBOV in Ebola virus disease (EVD), sponsored by University of Maryland, Baltimore. Started Oct 2014; status: completed.
02
Drugs
cAd3-EBOV
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT02267109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02267109.